Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia
- PMID: 19716560
- PMCID: PMC2783250
- DOI: 10.1016/j.ijgo.2009.07.037
Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia
Abstract
Objective: We assessed the effect of prenatal and peripartum antibiotics on maternal morbidity and mortality among HIV-infected and uninfected women.
Methods: A multicenter trial was conducted at clinical sites in 4 Sub-Saharan African cities: Blantyre and Lilongwe, Malawi; Dar es Salaam, Tanzania; and Lusaka, Zambia. A total of 1558 HIV-infected and 271 uninfected pregnant women who were eligible to receive both the prenatal and peripartum antibiotic/placebo regimens were enrolled. Pregnant women were interviewed at 20-24 weeks of gestation and a physical examination was performed. Women were randomized to receive either antibiotics or placebo. At the 26-30 week visit, participants were given antibiotics or placebo to be taken every 4 hours beginning at the onset of labor and continuing after delivery 3 times a day until a 1-week course was completed. Logistic regression and Cox proportional hazards models were used.
Results: There were no significant differences between the antibiotic and placebo groups for medical conditions, obstetric complications, physical examination findings, puerperal sepsis, and death in either the HIV-infected or the uninfected cohort.
Conclusion: Administration of study antibiotics during pregnancy had no effect on maternal morbidity and mortality among HIV-infected and uninfected pregnant women.
Conflict of interest statement
The conclusions and opinions expressed in this paper are those of the authors and do not necessarily reflect those of the funding agencies and participating institutions. The authors declare that there are no conflicts of interests.
References
-
- Parry S, Strauss JF., 3rd Premature rupture of the fetal membranes. N Engl J Med. 1998;338(10):663–670. - PubMed
-
- Goldenberg RL, Andrews WW, Yuan A, MacKay T, St Louis M. Sexually transmitted diseases and adverse outcomes of pregnancy. Clinics in Perinatology. 1997;24:23–41. - PubMed
-
- Andrews WW, Hauth JC, Cliver SP, Savage K, Goldenberg RL. Randomized clinical trial of extended antibiotic spectrum with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis. Obstet Gynecol. 2003;101(6):1183–1189. - PubMed
-
- Sebitloane HM, Moodley J, Esterhuizen TM. Prophylactic antibiotics for the prevention of postpartum infectious morbidity in women infected with human immunodeficiency virus: a randomized controlled trial. Am J Obstet Gynecol. 2008;198(2):e1–e6. 189. - PubMed
-
- Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol. 2003;101(5 Pt 1):847–855. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- D43-TW01035-07/TW/FIC NIH HHS/United States
- N01 AI045200/AI/NIAID NIH HHS/United States
- N01 AI035173/AI/NIAID NIH HHS/United States
- U01-AI-048006/AI/NIAID NIH HHS/United States
- U01 AI048006/AI/NIAID NIH HHS/United States
- N01-AI-035173-117/412/AI/NIAID NIH HHS/United States
- U01 AI048005/AI/NIAID NIH HHS/United States
- U01-AI-047972/AI/NIAID NIH HHS/United States
- U01 AI047972/AI/NIAID NIH HHS/United States
- N01-AI-035173/AI/NIAID NIH HHS/United States
- D43 TW001035/TW/FIC NIH HHS/United States
- U01-AI-048005/AI/NIAID NIH HHS/United States
- N01-AI-045200/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
